These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 2573416)
21. Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates. Fry DW; Besserer JA Cancer Res; 1988 Dec; 48(24 Pt 1):6986-91. PubMed ID: 2973370 [TBL] [Abstract][Full Text] [Related]
22. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359 [TBL] [Abstract][Full Text] [Related]
23. Cross-resistance to the lipid-soluble antifolate trimetrexate in human carcinoma cells with the multidrug-resistant phenotype. Assaraf YG; Molina A; Schimke RT J Natl Cancer Inst; 1989 Feb; 81(4):290-4. PubMed ID: 2521520 [TBL] [Abstract][Full Text] [Related]
24. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells. Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379 [TBL] [Abstract][Full Text] [Related]
25. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A. Gollapudi S; Gupta S Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515 [TBL] [Abstract][Full Text] [Related]
26. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha. Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669 [TBL] [Abstract][Full Text] [Related]
27. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells. Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205 [TBL] [Abstract][Full Text] [Related]
28. Biological activity and intracellular metabolism of ZD1694 in human leukemia cell lines with different resistance mechanisms to antifolate drugs. Takemura Y; Kobayashi H; Miyachi H; Gibson W; Kimbell R; Jackman AL Jpn J Cancer Res; 1996 Jul; 87(7):773-80. PubMed ID: 8698629 [TBL] [Abstract][Full Text] [Related]
29. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies. Politi PM; Arnold ST; Felsted RL; Sinha BK Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771 [TBL] [Abstract][Full Text] [Related]
30. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
31. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875 [TBL] [Abstract][Full Text] [Related]
32. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Harker WG; Sikic BI Cancer Res; 1985 Sep; 45(9):4091-6. PubMed ID: 4028002 [TBL] [Abstract][Full Text] [Related]
33. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. McGrath T; Center MS Cancer Res; 1988 Jul; 48(14):3959-63. PubMed ID: 2898287 [TBL] [Abstract][Full Text] [Related]
35. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin. Evans CH; Baker PD Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532 [TBL] [Abstract][Full Text] [Related]
37. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. Kavallaris M; Madafiglio J; Norris MD; Haber M Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a K562 multidrug-resistant cell line. Yanovich S; Hall RE; Gewirtz DA Cancer Res; 1989 Aug; 49(16):4499-503. PubMed ID: 2568171 [TBL] [Abstract][Full Text] [Related]
39. Relationship of VP-16 to the classical multidrug resistance phenotype. Sehested M; Friche E; Jensen PB; Demant EJ Cancer Res; 1992 May; 52(10):2874-9. PubMed ID: 1581902 [TBL] [Abstract][Full Text] [Related]
40. [Intracellular accumulation, retention, and distribution of anthracyclines in a multidrug-resistant variant K562r]. Hu X; Chen WY Zhongguo Yao Li Xue Bao; 1994 May; 15(3):275-9. PubMed ID: 7976387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]